$APYX
Apyx Medical Corp Stock $apyx

$apyx Overview Financials Valuation SEC Filings Company Website

2019 Q4 Form 10-Q Financial Statement

#000071913519000060 Filed on November 15, 2019

Income Statement

Concept	2019 Q4	2019 Q3	2019 Q2
Revenue	$8.382M	$7.575M	$6.649M
YoY Change	41.44%	106.29%	80.14%
Cost Of Revenue	$2.380M	$2.281M	$1.975M
YoY Change	3.93%	98.18%	71.14%
Gross Profit	$5.563M	$5.294M	$4.674M
YoY Change	56.44%	110.0%	84.23%
Gross Profit Margin	66.37%	69.89%	70.3%
Selling, General & Admin	$10.92M	$3.836M	$3.037M
YoY Change	36.84%	102.11%	37.23%
% of Gross Profit	196.3%	72.46%	64.98%
Research & Development	$1.100M	$1.016M	$888.0K
YoY Change	66.67%	65.74%	16.38%
% of Gross Profit	19.77%	19.19%	19.0%
Depreciation & Amortization	$240.0K	$190.0K	$130.0K
YoY Change	0.0%	227.59%	-24.42%
% of Gross Profit	4.31%	3.59%	2.78%
Operating Expenses	$12.02M	$10.05M	$9.096M
YoY Change	39.12%	89.3%	66.29%
Operating Profit	-$6.457M	-$4.756M	-$4.422M
YoY Change	27.01%	70.59%	50.77%
Interest Expense	$230.0K	$0.00	$0.00
YoY Change	-52.08%	-100.0%	-100.0%
% of Operating Profit
Other Income/Expense, Net	-$360.0K	$557.0K	$203.0K
YoY Change	-54.43%	-173.0%	2437.5%
Pretax Income	-$6.060M	-$4.199M	-$4.219M
YoY Change	-1.3%	18.25%	44.24%
Income Tax	-$250.0K	$171.0K	$76.00K
% Of Pretax Income
Net Earnings	-$5.810M	-$4.370M	-$4.338M
YoY Change	10.67%	-106.38%	47.65%
Net Earnings / Revenue	-69.32%	-57.69%	-65.24%
Basic Earnings Per Share		-$0.13	-$0.13
Diluted Earnings Per Share	-$168.1K	-$0.13	-$0.13
COMMON SHARES
Basic Shares Outstanding	34.17M shares	33.92M shares	34.04M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2019 Q4	2019 Q3	2019 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$58.80M	$62.30M	$67.40M
YoY Change	-24.9%	-35.17%	753.16%
Cash & Equivalents	$58.81M	$62.27M	$67.36M
Short-Term Investments	$0.00	$0.00	$0.00
Other Short-Term Assets	$3.600M	$1.700M	$2.000M
YoY Change	9.09%	183.33%	53.85%
Inventory	$5.068M	$7.237M	$6.392M
Prepaid Expenses
Receivables	$7.987M	$7.662M	$5.292M
Other Receivables	$1.233M	$0.00	$0.00
Total Short-Term Assets	$76.73M	$78.91M	$81.96M
YoY Change	-14.58%	-26.22%	268.71%
LONG-TERM ASSETS
Property, Plant & Equipment	$6.618M	$6.645M	$6.300M
YoY Change	14.34%	13.75%	-0.22%
Goodwill			$185.0K
YoY Change			0.0%
Intangibles			$185.0K
YoY Change			-87.75%
Long-Term Investments
YoY Change
Other Assets	$391.0K	$387.0K	$445.0K
YoY Change	28.2%	0.52%	564.18%
Total Long-Term Assets	$8.012M	$8.038M	$6.926M
YoY Change	31.5%	29.08%	-17.8%
TOTAL ASSETS
Total Short-Term Assets	$76.73M	$78.91M	$81.96M
Total Long-Term Assets	$8.012M	$8.038M	$6.926M
Total Assets	$84.75M	$86.94M	$88.88M
YoY Change	-11.66%	-23.18%	189.96%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.438M	$1.457M	$1.641M
YoY Change	71.33%	-37.95%	-40.22%
Accrued Expenses	$9.396M	$7.285M	$5.848M
YoY Change	30.72%	-63.73%	141.65%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$400.0K	$200.0K
YoY Change
Total Short-Term Liabilities	$12.31M	$9.039M	$7.897M
YoY Change	42.97%	-59.71%	26.62%
LONG-TERM LIABILITIES
Long-Term Debt	$400.0K	$600.0K	$100.0K
YoY Change			-95.72%
Other Long-Term Liabilities	$114.0K	$600.0K	$300.0K
YoY Change
Total Long-Term Liabilities	$114.0K	$1.200M	$400.0K
YoY Change			-82.87%
TOTAL LIABILITIES
Total Short-Term Liabilities	$12.31M	$9.039M	$7.897M
Total Long-Term Liabilities	$114.0K	$1.200M	$400.0K
Total Liabilities	$13.49M	$10.21M	$8.304M
YoY Change	54.11%	-54.77%	-8.55%
SHAREHOLDERS EQUITY
Retained Earnings	$14.52M	$19.95M	$24.32M
YoY Change	-57.58%	-48.54%	-181.88%
Common Stock	$34.00K	$34.00K	$34.00K
YoY Change	0.0%	3.03%	3.03%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$71.26M	$76.73M	$79.44M
YoY Change
Total Liabilities & Shareholders Equity	$84.75M	$86.94M	$88.88M
YoY Change	-11.66%	-23.18%	189.96%

Cashflow Statement

Concept	2019 Q4	2019 Q3	2019 Q2
OPERATING ACTIVITIES
Net Income	-$5.810M	-$4.370M	-$4.338M
YoY Change	10.67%	-106.38%	47.65%
Depreciation, Depletion And Amortization	$240.0K	$190.0K	$130.0K
YoY Change	0.0%	227.59%	-24.42%
Cash From Operating Activities	-$3.260M	-$4.540M	-$5.590M
YoY Change	-81.93%	291.38%	880.7%
INVESTING ACTIVITIES
Capital Expenditures	-$220.0K	-$560.0K	-$400.0K
YoY Change	37.5%	-530.77%	110.53%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$0.00	$40.88M
YoY Change	-100.0%	-100.0%
Cash From Investing Activities	-$230.0K	-$550.0K	$40.48M
YoY Change	-96.27%	-101.54%	-21405.26%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	0.000	30.00K	50.00K
YoY Change	-100.0%	-101.2%	-183.33%
NET CHANGE
Cash From Operating Activities	-3.260M	-4.540M	-5.590M
Cash From Investing Activities	-230.0K	-550.0K	40.48M
Cash From Financing Activities	0.000	30.00K	50.00K
Net Change In Cash	-3.490M	-5.060M	34.94M
YoY Change	-85.49%	-115.75%	-4360.98%
FREE CASH FLOW
Cash From Operating Activities	-$3.260M	-$4.540M	-$5.590M
Capital Expenditures	-$220.0K	-$560.0K	-$400.0K
Free Cash Flow	-$3.040M	-$3.980M	-$5.190M
YoY Change	-83.0%	208.53%	1265.79%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2018Q4	apyx	Accrued Professional Fees And Insurance Curren AccruedProfessionalFeesAndInsuranceCurren	725000	USD
CY2019Q3	apyx	Accrued Professional Fees And Insurance Curren AccruedProfessionalFeesAndInsuranceCurren	1649000	USD
	apyx	Finance Lease Payments FinanceLeasePayments	12000	USD
CY2018Q3	apyx	Incomelossfromdiscontinuedoperationsanddisposalofdiscontinuedoperationsnetoftax Incomelossfromdiscontinuedoperationsanddisposalofdiscontinuedoperationsnetoftax	69612000	USD
	apyx	Incomelossfromdiscontinuedoperationsanddisposalofdiscontinuedoperationsnetoftax Incomelossfromdiscontinuedoperationsanddisposalofdiscontinuedoperationsnetoftax	74134000	USD
CY2019Q3	apyx	Incomelossfromdiscontinuedoperationsanddisposalofdiscontinuedoperationsnetoftax Incomelossfromdiscontinuedoperationsanddisposalofdiscontinuedoperationsnetoftax	0	USD
	apyx	Incomelossfromdiscontinuedoperationsanddisposalofdiscontinuedoperationsnetoftax Incomelossfromdiscontinuedoperationsanddisposalofdiscontinuedoperationsnetoftax	0	USD
	apyx	Non Cash Proceeds From Stock Options And Warrants Exercised NonCashProceedsFromStockOptionsAndWarrantsExercised	3133000	USD
	apyx	Non Cash Proceeds From Stock Options And Warrants Exercised NonCashProceedsFromStockOptionsAndWarrantsExercised	957000	USD
	apyx	Operating Lease Foreign Currency Transaction Gain Loss OperatingLeaseForeignCurrencyTransactionGainLoss	14000	USD
	apyx	Operating Lease Liability Increase Decrease OperatingLeaseLiabilityIncreaseDecrease	-90000	USD
	apyx	Operating Lease Right Of Use Asset Increase Decrease OperatingLeaseRightOfUseAssetIncreaseDecrease	-78000	USD
CY2018Q4	apyx	Other Accrued Expenses And Liabilities Current OtherAccruedExpensesAndLiabilitiesCurrent	3058000	USD
CY2019Q3	apyx	Other Accrued Expenses And Liabilities Current OtherAccruedExpensesAndLiabilitiesCurrent	3392000	USD
	apyx	Proceeds From Stock Options Exercised And Warrants Exercised ProceedsFromStockOptionsExercisedAndWarrantsExercised	65000	USD
	apyx	Proceeds From Stock Options Exercised And Warrants Exercised ProceedsFromStockOptionsExercisedAndWarrantsExercised	154000	USD
	apyx	Provision For Inventory Obsolescence ProvisionForInventoryObsolescence	0	USD
	apyx	Provision For Inventory Obsolescence ProvisionForInventoryObsolescence	115000	USD
CY2018Q4	apyx	Provision For Obsolescence Inventory ProvisionForObsolescenceInventory	439000	USD
CY2019Q3	apyx	Provision For Obsolescence Inventory ProvisionForObsolescenceInventory	439000	USD
	apyx	Repaymentof Finance Lease Liabilities RepaymentofFinanceLeaseLiabilities	0	USD
	apyx	Repaymentof Finance Lease Liabilities RepaymentofFinanceLeaseLiabilities	2000	USD
CY2018Q3	apyx	Share Based Compensation Arrangement By Share Based Payment Award Options Surrendered In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsSurrenderedInPeriod	532477	shares
	apyx	Share Based Compensation Arrangement By Share Based Payment Award Options Surrendered In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsSurrenderedInPeriod	576135	shares
CY2019Q3	apyx	Share Based Compensation Arrangement By Share Based Payment Award Options Surrendered In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsSurrenderedInPeriod	26572	shares
	apyx	Share Based Compensation Arrangement By Share Based Payment Award Options Surrendered In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsSurrenderedInPeriod	118170	shares
CY2018Q3	apyx	Stock Swap To Acquire Options Amount StockSwapToAcquireOptionsAmount	0	USD
	apyx	Stock Swap To Acquire Options Amount StockSwapToAcquireOptionsAmount	0	USD
CY2019Q3	apyx	Stock Swap To Acquire Options Amount StockSwapToAcquireOptionsAmount	0	USD
	apyx	Stock Swap To Acquire Options Amount StockSwapToAcquireOptionsAmount	0	USD
CY2018Q3	apyx	Stock Swap To Acquire Options Shares StockSwapToAcquireOptionsShares	680388	shares
	apyx	Stock Swap To Acquire Options Shares StockSwapToAcquireOptionsShares	713980	shares
CY2019Q3	apyx	Stock Swap To Acquire Options Shares StockSwapToAcquireOptionsShares	34928	shares
	apyx	Stock Swap To Acquire Options Shares StockSwapToAcquireOptionsShares	220879	shares
	apyx	Stock Swap To Acquire Warrants Amount StockSwapToAcquireWarrantsAmount	0	USD
CY2018Q3	apyx	Total Revenue Percent TotalRevenuePercent	0.248
	apyx	Total Revenue Percent TotalRevenuePercent	0.212
CY2019Q3	apyx	Total Revenue Percent TotalRevenuePercent	0.267
	apyx	Total Revenue Percent TotalRevenuePercent	0.292
CY2018Q3	apyx	Weighted Average Numberof Shares Issued Basic And Diluted Discontinued Operations WeightedAverageNumberofSharesIssuedBasicAndDilutedDiscontinuedOperations	34934000	shares
	apyx	Weighted Average Numberof Shares Issued Basic And Diluted Discontinued Operations WeightedAverageNumberofSharesIssuedBasicAndDilutedDiscontinuedOperations	33952000	shares
CY2019Q3	apyx	Weighted Average Numberof Shares Issued Basic And Diluted Discontinued Operations WeightedAverageNumberofSharesIssuedBasicAndDilutedDiscontinuedOperations	34078000	shares
	apyx	Weighted Average Numberof Shares Issued Basic And Diluted Discontinued Operations WeightedAverageNumberofSharesIssuedBasicAndDilutedDiscontinuedOperations	34039000	shares
CY2018Q3	apyx	Weighted Average Numberof Shares Issued Basic Continuing Operations WeightedAverageNumberofSharesIssuedBasicContinuingOperations	33275000	shares
	apyx	Weighted Average Numberof Shares Issued Basic Continuing Operations WeightedAverageNumberofSharesIssuedBasicContinuingOperations	33014000	shares
	apyx	Lessee Discount Rate Incremental Borrowing Rate LesseeDiscountRateIncrementalBorrowingRate	0.0400
CY2019Q3	apyx	Weighted Average Numberof Shares Issued Basic Continuing Operations WeightedAverageNumberofSharesIssuedBasicContinuingOperations	33942000	shares
	apyx	Weighted Average Numberof Shares Issued Basic Continuing Operations WeightedAverageNumberofSharesIssuedBasicContinuingOperations	33903000	shares
CY2018Q3	apyx	Weighted Average Shares Outstanding Basic And Diluted Continuing Operations WeightedAverageSharesOutstandingBasicAndDilutedContinuingOperations	33275000	shares
	apyx	Weighted Average Shares Outstanding Basic And Diluted Continuing Operations WeightedAverageSharesOutstandingBasicAndDilutedContinuingOperations	33014000	shares
CY2019Q3	apyx	Weighted Average Shares Outstanding Basic And Diluted Continuing Operations WeightedAverageSharesOutstandingBasicAndDilutedContinuingOperations	34078000	shares
	apyx	Weighted Average Shares Outstanding Basic And Diluted Continuing Operations WeightedAverageSharesOutstandingBasicAndDilutedContinuingOperations	34039000	shares
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2019
	dei	Document Period End Date DocumentPeriodEndDate	2019-09-30
	dei	Document Type DocumentType	10-Q
	dei	Entity Central Index Key EntityCentralIndexKey	0000719135
CY2019Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	34168230	shares
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
	dei	Entity Registrant Name EntityRegistrantName	APYX MEDICAL CORP
	dei	Entity Shell Company EntityShellCompany	false
	dei	Entity Small Business EntitySmallBusiness	true
CY2018Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1423000	USD
CY2019Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	1457000	USD
CY2018Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	5015000	USD
CY2019Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	7662000	USD
CY2018Q4	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	972000	USD
CY2019Q3	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	936000	USD
CY2018Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	6162000	USD
CY2019Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	7285000	USD
CY2018Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	418000	USD
CY2019Q3	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	289000	USD
CY2018Q4	us-gaap	Accrued Sales Commission Current AccruedSalesCommissionCurrent	379000	USD
CY2019Q3	us-gaap	Accrued Sales Commission Current AccruedSalesCommissionCurrent	784000	USD
CY2018Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	52920000	USD
CY2019Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	54182000	USD
CY2019Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	55086000	USD
CY2019Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	55668000	USD
CY2018Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	489000	USD
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1238000	USD
CY2019Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	543000	USD
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2594000	USD
CY2018Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	489000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1238000	USD
CY2019Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	543000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2594000	USD
CY2018Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	428000	USD
CY2019Q3	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	354000	USD
CY2018Q4	us-gaap	Assets Assets	95610000	USD
CY2019Q3	us-gaap	Assets Assets	86943000	USD
CY2018Q4	us-gaap	Assets Current AssetsCurrent	89517000	USD
CY2019Q3	us-gaap	Assets Current AssetsCurrent	78905000	USD
CY2018Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	247000	USD
CY2018Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	77897000	USD
CY2018Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	78144000	USD
CY2018Q4	us-gaap	Cash Cash	6337000	USD
CY2019Q3	us-gaap	Cash Cash	1300000	USD
CY2018Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	16466000	USD
CY2019Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	62272000	USD
CY2017Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	10668000	USD
CY2018Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	40663000	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	16466000	USD
CY2019Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	62272000	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	29995000	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	45806000	USD
CY2018Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2019Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2018Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	75000000	shares
CY2019Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	75000000	shares
CY2018Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	33847100	shares
CY2019Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	34120065	shares
CY2018Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	33704525	shares
CY2019Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	33977490	shares
CY2018Q4	us-gaap	Common Stock Value CommonStockValue	34000	USD
CY2019Q3	us-gaap	Common Stock Value CommonStockValue	34000	USD
CY2018Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	0	USD
CY2019Q1	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	194000	USD
CY2019Q2	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	194000	USD
CY2019Q3	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	339000	USD
CY2018Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1151000	USD
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	3490000	USD
CY2019Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	2558000	USD
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	6757000	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-368000	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	429000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	510000	USD
CY2018Q3	us-gaap	Discontinued Operation Gain Loss On Disposal Of Discontinued Operation Net Of Tax DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax	69072000	USD
	us-gaap	Discontinued Operation Gain Loss On Disposal Of Discontinued Operation Net Of Tax DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax	69072000	USD
CY2019Q3	us-gaap	Discontinued Operation Gain Loss On Disposal Of Discontinued Operation Net Of Tax DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax	0	USD
	us-gaap	Discontinued Operation Gain Loss On Disposal Of Discontinued Operation Net Of Tax DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax	0	USD
CY2018Q3	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare	2.09
	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare	2.25
CY2018	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare	2.21
CY2019Q3	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare	0.00
	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare	0.00
CY2018Q3	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Diluted Share DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare	1.99
	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Diluted Share DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare	2.19
CY2018	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Diluted Share DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare	2.14
CY2019Q3	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Diluted Share DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare	0.00
	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Diluted Share DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare	0.00
CY2018Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.08
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.06
CY2018	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.91
CY2019Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.13
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.41
CY2018Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.98
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.00
CY2018	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.85
CY2019Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.13
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.41
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	0	USD
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-18000	USD
CY2018Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.846
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.279
CY2019Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.041
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.009
CY2019Q3	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	94000	USD
CY2019Q3	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	0	USD
	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	0	USD
CY2019Q3	us-gaap	Finance Lease Liability FinanceLeaseLiability	640000	USD
CY2019Q3	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	196000	USD
CY2019Q3	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	444000	USD
CY2019Q3	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	683000	USD
CY2019Q3	us-gaap	Finance Lease Liability Payments Due Year Five FinanceLeaseLiabilityPaymentsDueYearFive	18000	USD
CY2019Q3	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour	170000	USD
CY2019Q3	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree	220000	USD
CY2019Q3	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	220000	USD
CY2019Q3	us-gaap	Finance Lease Liability Payments Remainder Of Fiscal Year FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear	55000	USD
CY2019Q3	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	43000	USD
CY2019Q3	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	638000	USD
CY2019Q3	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	4000	USD
	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	4000	USD
CY2019Q3	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P3Y
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	0	USD
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	12000	USD
	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	0	USD
	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-19000	USD
	us-gaap	Gain Loss On Investments GainLossOnInvestments	47000	USD
	us-gaap	Gain Loss On Investments GainLossOnInvestments	164000	USD
CY2018Q3	us-gaap	Gross Profit GrossProfit	2521000	USD
	us-gaap	Gross Profit GrossProfit	7270000	USD
CY2019Q3	us-gaap	Gross Profit GrossProfit	5017000	USD
	us-gaap	Gross Profit GrossProfit	13015000	USD
CY2018Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2846000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-8551000	USD
CY2019Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-4140000	USD
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	0	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-13777000	USD
CY2018Q3	us-gaap	Income Loss From Continuing Operations Per Basic And Diluted Share IncomeLossFromContinuingOperationsPerBasicAndDilutedShare	-0.01
	us-gaap	Income Loss From Continuing Operations Per Basic And Diluted Share IncomeLossFromContinuingOperationsPerBasicAndDilutedShare	-0.19
CY2018	us-gaap	Income Loss From Continuing Operations Per Basic And Diluted Share IncomeLossFromContinuingOperationsPerBasicAndDilutedShare	-0.30
CY2019Q1	us-gaap	Income Loss From Continuing Operations Per Basic And Diluted Share IncomeLossFromContinuingOperationsPerBasicAndDilutedShare	-0.16
	us-gaap	Income Loss From Continuing Operations Per Basic And Diluted Share IncomeLossFromContinuingOperationsPerBasicAndDilutedShare	-0.29
CY2019Q3	us-gaap	Income Loss From Continuing Operations Per Basic And Diluted Share IncomeLossFromContinuingOperationsPerBasicAndDilutedShare	-0.13
	us-gaap	Income Loss From Continuing Operations Per Basic And Diluted Share IncomeLossFromContinuingOperationsPerBasicAndDilutedShare	-0.41
CY2018Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	540000	USD
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	5062000	USD
CY2019Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	0	USD
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	0	USD
CY2018Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-2408000	USD
CY2018Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-2400000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-2384000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-2400000	USD
CY2019Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	171000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	123000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	765000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	50000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-654000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	2580000	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-2601000	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	1556000	USD
	us-gaap	Increase Decrease In Deposits IncreaseDecreaseInDeposits	-9000	USD
	us-gaap	Increase Decrease In Deposits IncreaseDecreaseInDeposits	-131000	USD
	us-gaap	Increase Decrease In Derivative Liabilities IncreaseDecreaseInDerivativeLiabilities	-20000	USD
	us-gaap	Increase Decrease In Derivative Liabilities IncreaseDecreaseInDerivativeLiabilities	0	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1706000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	2463000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	188000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	596000	USD
CY2018Q3	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	1659000	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	938000	shares
CY2019Q3	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
CY2018Q3	us-gaap	Interest Expense InterestExpense	30000	USD
	us-gaap	Interest Expense InterestExpense	102000	USD
CY2019Q3	us-gaap	Interest Expense InterestExpense	0	USD
	us-gaap	Interest Expense InterestExpense	0	USD
CY2018Q3	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	105000	USD
	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	33000	USD
CY2018Q3	us-gaap	Interest Income Operating InterestIncomeOperating	135000	USD
	us-gaap	Interest Income Operating InterestIncomeOperating	135000	USD
CY2019Q3	us-gaap	Interest Income Operating InterestIncomeOperating	327000	USD
	us-gaap	Interest Income Operating InterestIncomeOperating	1153000	USD
	us-gaap	Interest Paid Net InterestPaidNet	102000	USD
	us-gaap	Interest Paid Net InterestPaidNet	0	USD
CY2018Q4	us-gaap	Inventory Finished Goods And Work In Process InventoryFinishedGoodsAndWorkInProcess	1130000	USD
CY2019Q3	us-gaap	Inventory Finished Goods And Work In Process InventoryFinishedGoodsAndWorkInProcess	1550000	USD
CY2018Q4	us-gaap	Inventory Gross InventoryGross	5651000	USD
CY2019Q3	us-gaap	Inventory Gross InventoryGross	7676000	USD
CY2018Q4	us-gaap	Inventory Net InventoryNet	5212000	USD
CY2019Q3	us-gaap	Inventory Net InventoryNet	7237000	USD
CY2018Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	4521000	USD
CY2019Q3	us-gaap	Inventory Raw Materials InventoryRawMaterials	6126000	USD
CY2018Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	439000	USD
CY2019Q3	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	439000	USD
CY2019Q3	us-gaap	Lease Cost LeaseCost	39000	USD
	us-gaap	Lease Cost LeaseCost	100000	USD
CY2019Q1	us-gaap	Lessee Operating Lease Discount Rate LesseeOperatingLeaseDiscountRate	0.0400
CY2019Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	372000	USD
CY2019Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	221000	USD
CY2019Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	0	USD
CY2019Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	114000	USD
CY2019Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	117000	USD
CY2019Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	113000	USD
CY2019Q3	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	28000	USD
CY2019Q3	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	23000	USD
CY2018Q4	us-gaap	Liabilities Liabilities	7725000	USD
CY2019Q3	us-gaap	Liabilities Liabilities	10210000	USD
CY2018Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	95610000	USD
CY2019Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	86943000	USD
CY2018Q4	us-gaap	Liabilities Current LiabilitiesCurrent	7585000	USD
CY2019Q3	us-gaap	Liabilities Current LiabilitiesCurrent	9039000	USD
CY2018Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	140000	USD
CY2019Q3	us-gaap	Long Term Notes Payable LongTermNotesPayable	140000	USD
CY2019Q3	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	61000000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-2629000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	152000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	35459000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	60766000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2835000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-15094000	USD
CY2018Q3	us-gaap	Net Income Loss NetIncomeLoss	-438000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-6167000	USD
CY2019Q3	us-gaap	Net Income Loss NetIncomeLoss	-4311000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-13900000	USD
CY2018Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	69174000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	67967000	USD
CY2019Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-4311000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-13900000	USD
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	2	segment
CY2018Q3	us-gaap	Operating Expenses OperatingExpenses	5317000	USD
	us-gaap	Operating Expenses OperatingExpenses	15719000	USD
CY2019Q3	us-gaap	Operating Expenses OperatingExpenses	9714000	USD
	us-gaap	Operating Expenses OperatingExpenses	27950000	USD
CY2018Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-2796000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-8449000	USD
CY2019Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-4697000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-14935000	USD
CY2019Q3	us-gaap	Operating Lease Cost OperatingLeaseCost	30000	USD
	us-gaap	Operating Lease Cost OperatingLeaseCost	85000	USD
	us-gaap	Operating Lease Expense OperatingLeaseExpense	2000	USD
CY2019Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	349000	USD
CY2019Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	101000	USD
CY2019Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	248000	USD
	us-gaap	Operating Lease Payments OperatingLeasePayments	85000	USD
CY2019Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	368000	USD
CY2019Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0404
CY2019Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P3Y2M12D
CY2018Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	305000	USD
CY2019Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	239000	USD
CY2019Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	445000	USD
CY2019Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	387000	USD
CY2018Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-50000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-102000	USD
CY2019Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	557000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1158000	USD
CY2018Q3	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-155000	USD
	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-155000	USD
CY2019Q3	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	230000	USD
	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	5000	USD
	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	55433000	USD
	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	18884000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	203000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1076000	USD
CY2018Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1146000	USD
CY2019Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1734000	USD
CY2018Q3	us-gaap	Proceeds From Divestiture Of Businesses ProceedsFromDivestitureOfBusinesses	97000000	USD
	us-gaap	Proceeds From Divestiture Of Businesses ProceedsFromDivestitureOfBusinesses	91095000	USD
	us-gaap	Proceeds From Divestiture Of Businesses ProceedsFromDivestitureOfBusinesses	0	USD
	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	0	USD
	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	80726000	USD
CY2018Q3	us-gaap	Professional Fees ProfessionalFees	628000	USD
	us-gaap	Professional Fees ProfessionalFees	1815000	USD
CY2018	us-gaap	Professional Fees ProfessionalFees	3106000	USD
CY2019Q1	us-gaap	Professional Fees ProfessionalFees	2127000	USD
	us-gaap	Professional Fees ProfessionalFees	3760000	USD
CY2019Q3	us-gaap	Professional Fees ProfessionalFees	1996000	USD
	us-gaap	Professional Fees ProfessionalFees	5756000	USD
CY2018Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5788000	USD
CY2019Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	6645000	USD
CY2019Q3	us-gaap	Purchase Commitment Remaining Minimum Amount Committed PurchaseCommitmentRemainingMinimumAmountCommitted	4600000	USD
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	2694000	USD
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	123000	USD
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-94000	USD
CY2018Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	613000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1890000	USD
CY2019Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	936000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2634000	USD
CY2018Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	34931000	USD
CY2019Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	29680000	USD
CY2019Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	25342000	USD
CY2019Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	21031000	USD
CY2018Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3672000	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	10760000	USD
CY2019Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	5629000	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	12197000	USD
CY2019Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	7575000	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	19772000	USD
CY2018Q3	us-gaap	Salaries And Wages SalariesAndWages	2119000	USD
	us-gaap	Salaries And Wages SalariesAndWages	5734000	USD
CY2018	us-gaap	Salaries And Wages SalariesAndWages	9221000	USD
CY2019Q1	us-gaap	Salaries And Wages SalariesAndWages	3338000	USD
	us-gaap	Salaries And Wages SalariesAndWages	6671000	USD
CY2019Q3	us-gaap	Salaries And Wages SalariesAndWages	3020000	USD
	us-gaap	Salaries And Wages SalariesAndWages	9691000	USD
CY2018Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1957000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	6280000	USD
CY2019Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	3024000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	6107000	USD
CY2019Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	3762000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	9869000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	1238000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	2594000	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum	0.691
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum	0.676
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	183500	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	3.41
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	1379500	shares
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3254779	shares
CY2019Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	4059643	shares
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.18
CY2019Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	4.73
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	2.84
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	7.70
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y
CY2018Q4	us-gaap	Short Term Investments ShortTermInvestments	61678000	USD
CY2019Q3	us-gaap	Short Term Investments ShortTermInvestments	0	USD
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	391135	shares
CY2018Q3	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	65000	USD
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	65000	USD
CY2019Q3	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	39000	USD
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	154000	USD
CY2017Q4	us-gaap	Stockholders Equity StockholdersEquity	22032000	USD
CY2018Q2	us-gaap	Stockholders Equity StockholdersEquity	21574000	USD
CY2018Q3	us-gaap	Stockholders Equity StockholdersEquity	91302000	USD
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	87885000	USD
CY2019Q2	us-gaap	Stockholders Equity StockholdersEquity	80462000	USD
CY2019Q3	us-gaap	Stockholders Equity StockholdersEquity	76733000	USD
CY2018Q4	us-gaap	Supplemental Unemployment Benefits Severance Benefits SupplementalUnemploymentBenefitsSeveranceBenefits	610000	USD
CY2019Q3	us-gaap	Supplemental Unemployment Benefits Severance Benefits SupplementalUnemploymentBenefitsSeveranceBenefits	235000	USD
CY2018Q3	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	0	USD
	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	20000	USD
CY2019Q3	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	0	USD
	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	0	USD
CY2018Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	1313000	USD
CY2019Q3	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	1313000	USD
	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	0	USD
CY2019Q3	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	197000	USD
CY2019Q3	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	146000	USD
	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	197000	USD
	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	0	USD
	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	0	USD
CY2019Q3	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	1510000	USD
CY2019Q3	us-gaap	Variable Lease Cost VariableLeaseCost	5000	USD
	us-gaap	Variable Lease Cost VariableLeaseCost	11000	USD
CY2018Q3	us-gaap	Weighted Average Number Of Shares Contingently Issuable WeightedAverageNumberOfSharesContingentlyIssuable	0	shares
	us-gaap	Weighted Average Number Of Shares Contingently Issuable WeightedAverageNumberOfSharesContingentlyIssuable	0	shares
CY2019Q3	us-gaap	Weighted Average Number Of Shares Contingently Issuable WeightedAverageNumberOfSharesContingentlyIssuable	136000	shares
	us-gaap	Weighted Average Number Of Shares Contingently Issuable WeightedAverageNumberOfSharesContingentlyIssuable	136000	shares
	us-gaap	Description Of New Accounting Pronouncements Not Yet Adopted DescriptionOfNewAccountingPronouncementsNotYetAdopted	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">RECENT ACCOUNTING PRONOUNCEMENTS </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In January 2017, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2017-04, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Intangibles-Goodwill and Other</font><font style="font-family:inherit;font-size:10pt;"> (Topic 350): </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Simplifying the Test for Goodwill Impairment</font><font style="font-family:inherit;font-size:10pt;">. The purpose of this ASU is to reduce the cost and complexity of evaluating goodwill for impairment. It eliminates the need for entities to calculate the implied fair value of goodwill by assigning the fair value of a reporting unit to all of its assets and liabilities as if that reporting unit had been acquired in a business combination. Under this ASU, an entity will perform its goodwill impairment test by comparing the fair value of a reporting unit with its carrying amount. An impairment charge is recognized for the amount by which the carrying value exceeds the reporting unit’s fair value. The new standard is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2019. Early adoption is permitted, however we have chosen not to do so. The amendment will not have a material impact on our </font><font style="font-family:inherit;font-size:10pt;">consolidated </font><font style="font-family:inherit;font-size:10pt;">financial condition or results of operations.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In February 2016, the FASB issued ASU 2016-02, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Leases </font><font style="font-family:inherit;font-size:10pt;">(Topic 842). Topic 842 establishes a new lease model, referred to as the right-of-use model that brings substantially all leases on the balance sheet. This standard requires lessees to recognize leased assets and lease liabilities on the balance sheet and disclose key information about the leasing arrangements in their financial statements. Leases are classified as finance or operating, with classification affecting the pattern and classification of expense recognition in the statement of operations. The Company adopted Topic 842 effective January 1, 2019 using the modified retrospective transition approach that allows a reporting entity to use the effective date as its date of initial application and not restate the comparative periods in the period of adoption when transitioning to the new standard. Consequently, the requisite financial information and disclosures under the new standard are excluded for dates and periods prior to January 1, 2019. In addition, the Company elected to use a number of optional simplification and practical expedients permitted under the transition guidance within the new standard, including allowing the Company to combine fixed lease and non-lease components, apply the short-term lease exception to all leases of one year or less, and utilize the ‘package of practical expedients’, which permits the Company to not reassess prior accounting conclusions with respect to lease identification, lease classification and initial direct costs under Topic 842. Adoption of this new standard resulted in the recognition of approximately </font><font style="font-family:inherit;font-size:10pt;">$212,000</font><font style="font-family:inherit;font-size:10pt;"> of operating lease liabilities and right-of-user assets, which represents the present value of the remaining lease payments at the adoption date of approximately </font><font style="font-family:inherit;font-size:10pt;">$221,000</font><font style="font-family:inherit;font-size:10pt;">, discounted using the Company’s incremental borrowing rate of </font><font style="font-family:inherit;font-size:10pt;">4.00%</font><font style="font-family:inherit;font-size:10pt;">. Please see Note 13 for a full discussion of the impacts of adoption on the current year consolidated financial statements. </font></div><div style="line-height:120%;padding-bottom:13px;text-align:justify;"></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">No other new accounting pronouncement issued or effective during the fiscal year had or is expected to have a material impact on our consolidated financial statements or disclosures.</font></div></div>

Files In Submission

Name	View Source	Status
0000719135-19-000060-index-headers.html	Edgar Link	pending
0000719135-19-000060-index.html	Edgar Link	pending
0000719135-19-000060.txt	Edgar Link	pending
0000719135-19-000060-xbrl.zip	Edgar Link	pending
a2019q310-q.htm	Edgar Link	pending
a2019q3apyx10-qexhibit311.htm	Edgar Link	pending
a2019q3apyx10-qexhibit312.htm	Edgar Link	pending
a2019q3apyx10-qexhibit321.htm	Edgar Link	pending
a2019q3apyx10-qexhibit322.htm	Edgar Link	pending
apyx-20190930.xml	Edgar Link	completed
apyx-20190930.xsd	Edgar Link	pending
apyx-20190930_cal.xml	Edgar Link	unprocessable
apyx-20190930_def.xml	Edgar Link	unprocessable
apyx-20190930_lab.xml	Edgar Link	unprocessable
apyx-20190930_pre.xml	Edgar Link	unprocessable
apyxmedicallogotagline.jpg	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$APYX
Apyx Medical Corp Stock $apyx

2019 Q4 Form 10-Q Financial Statement

#000071913519000060 Filed on November 15, 2019

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$APYX Apyx Medical Corp Stock $apyx

2019 Q4 Form 10-Q Financial Statement

#000071913519000060 Filed on November 15, 2019

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$APYX
Apyx Medical Corp Stock $apyx